These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10472759)

  • 1. Epidermal calprotectin in drug-induced toxic epidermal necrolysis.
    Paquet P; Piérard GE
    J Cutan Pathol; 1999 Jul; 26(6):301-5. PubMed ID: 10472759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis.
    Paquet P; Paquet F; Al Saleh W; Reper P; Vanderkelen A; Piérard GE
    Am J Dermatopathol; 2000 Oct; 22(5):413-7. PubMed ID: 11048976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin.
    Paquet P; Piérard GE
    Int J Mol Med; 2002 Aug; 10(2):145-7. PubMed ID: 12119549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor-XIIIa-positive dendrocytes in drug-induced toxic epidermal necrolysis (Lyell's syndrome): paradoxical activation in skin and rarefaction in lymph nodes.
    Paquet P; Quatresooz P; Piérard GE
    Dermatology; 2003; 206(4):374-8. PubMed ID: 12771490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of CD14+ CD16+ monocyte lineage cells in the epidermal damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tohyama M; Watanabe H; Murakami S; Shirakata Y; Sayama K; Iijima M; Hashimoto K
    Br J Dermatol; 2012 Feb; 166(2):322-30. PubMed ID: 21936856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythema multiforme and toxic epidermal necrolysis: a comparative study.
    Paquet P; Piérard GE
    Am J Dermatopathol; 1997 Apr; 19(2):127-32. PubMed ID: 9129696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced toxic epidermal necrolysis and pancytopenia: a puzzling association.
    Paquet P; Jacob E; Pirson J; Pierard GE
    Int J Mol Med; 2005 Jul; 16(1):29-33. PubMed ID: 15942674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated RIP3 Expression Potentiates MLKL Phosphorylation-Mediated Programmed Necrosis in Toxic Epidermal Necrolysis.
    Kim SK; Kim WJ; Yoon JH; Ji JH; Morgan MJ; Cho H; Kim YC; Kim YS
    J Invest Dermatol; 2015 Aug; 135(8):2021-2030. PubMed ID: 25748555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study.
    Paquet P; Jennes S; Rousseau AF; Libon F; Delvenne P; Piérard GE
    Burns; 2014 Dec; 40(8):1707-12. PubMed ID: 24726294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
    Nassif A; Moslehi H; Le Gouvello S; Bagot M; Lyonnet L; Michel L; Boumsell L; Bensussan A; Roujeau JC
    J Invest Dermatol; 2004 Nov; 123(5):850-5. PubMed ID: 15482470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.
    Paquet P; Arrese JE; Beguin Y; Piérard GE
    Curr Top Pathol; 2001; 94():49-63. PubMed ID: 11443887
    [No Abstract]   [Full Text] [Related]  

  • 13. A Review of the Pathogenesis of Toxic Epidermal Necrolysis.
    Kinoshita Y; Saeki H
    J Nippon Med Sch; 2016; 83(6):216-222. PubMed ID: 28133001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Expression of PD-L1 Is Increased in Lesional Epidermal Keratinocytes in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Ziemer CM; Miedema J; Smith CJ; Liu Z; Thomas NE; Googe PB
    Am J Dermatopathol; 2021 Apr; 43(4):318-320. PubMed ID: 33055536
    [No Abstract]   [Full Text] [Related]  

  • 15. Differential pathomechanisms of epidermal necrolytic blistering diseases.
    Paquet P; Piérard GE
    Int J Mol Med; 2002 Dec; 10(6):695-9. PubMed ID: 12429994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic kinetic analysis of blister fluid and serum in a patient with drug-induced toxic epidermal necrolysis. A comparison with skin immunohistochemistry.
    Paquet P; Meuwis MA; Mazzucchelli G; Delvenne P; Piérard GE
    Curr Drug Saf; 2012 Nov; 7(5):339-51. PubMed ID: 23373548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
    Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidermal necrolysis: mechanisms of keratinocyte apoptosis].
    Roujeau JC; Gélard K; Bensussan A
    Med Sci (Paris); 2006 Feb; 22(2):188-91. PubMed ID: 16457761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.
    Viard I; Wehrli P; Bullani R; Schneider P; Holler N; Salomon D; Hunziker T; Saurat JH; Tschopp J; French LE
    Science; 1998 Oct; 282(5388):490-3. PubMed ID: 9774279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of macrophages in the pathology of toxic epidermal necrolysis.
    Roujeau JC; Dubertret L; Moritz S; Jouault H; Heslan M; Revuz J; Touraine R
    Br J Dermatol; 1985 Oct; 113(4):425-30. PubMed ID: 4063178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.